100 related articles for article (PubMed ID: 27973981)
1. MYB-QKI drives childhood brain tumors via tripartite mechanism.
Jain P; Resnick AC
Cell Cycle; 2017 Mar; 16(5):390-391. PubMed ID: 27973981
[No Abstract] [Full Text] [Related]
2. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.
Bandopadhayay P; Ramkissoon LA; Jain P; Bergthold G; Wala J; Zeid R; Schumacher SE; Urbanski L; O'Rourke R; Gibson WJ; Pelton K; Ramkissoon SH; Han HJ; Zhu Y; Choudhari N; Silva A; Boucher K; Henn RE; Kang YJ; Knoff D; Paolella BR; Gladden-Young A; Varlet P; Pages M; Horowitz PM; Federation A; Malkin H; Tracy AA; Seepo S; Ducar M; Van Hummelen P; Santi M; Buccoliero AM; Scagnet M; Bowers DC; Giannini C; Puget S; Hawkins C; Tabori U; Klekner A; Bognar L; Burger PC; Eberhart C; Rodriguez FJ; Hill DA; Mueller S; Haas-Kogan DA; Phillips JJ; Santagata S; Stiles CD; Bradner JE; Jabado N; Goren A; Grill J; Ligon AH; Goumnerova L; Waanders AJ; Storm PB; Kieran MW; Ligon KL; Beroukhim R; Resnick AC
Nat Genet; 2016 Mar; 48(3):273-82. PubMed ID: 26829751
[TBL] [Abstract][Full Text] [Related]
3. MYB/MYBL1::QKI fusion-positive diffuse glioma.
Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
[TBL] [Abstract][Full Text] [Related]
4. MYB-QKI rearrangement in angiocentric glioma.
Lian F; Wang LM; Qi XL; Liu LN; Wang XF; Fu J; Xiong J; Lu DH; Piao YS
Clin Neuropathol; 2020; 39(6):263-270. PubMed ID: 32589128
[TBL] [Abstract][Full Text] [Related]
5. Brainstem angiocentric gliomas with MYB-QKI rearrangements.
D'Aronco L; Rouleau C; Gayden T; Crevier L; Décarie JC; Perreault S; Jabado N; Bandopadhayay P; Ligon KL; Ellezam B
Acta Neuropathol; 2017 Oct; 134(4):667-669. PubMed ID: 28803398
[No Abstract] [Full Text] [Related]
6. Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
Chan E; Bollen AW; Sirohi D; Van Ziffle J; Grenert JP; Kline CN; Tihan T; Perry A; Gupta N; Solomon DA
Acta Neuropathol; 2017 Oct; 134(4):671-673. PubMed ID: 28776091
[No Abstract] [Full Text] [Related]
7. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
8. ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.
Mertz JA; Kobayashi R; Dudley JP
J Virol; 2007 Apr; 81(7):3503-13. PubMed ID: 17229714
[TBL] [Abstract][Full Text] [Related]
9. [Expression and implication of c-myb and bcl-2 proteins in C6 gliomas].
You C; Xu X; Cal B; Zhang S
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):304-5, 318. PubMed ID: 12545815
[TBL] [Abstract][Full Text] [Related]
10. c-Myb protein interacts with Rcd-1, a component of the CCR4 transcription mediator complex.
Haas M; Siegert M; Schürmann A; Sodeik B; Wolfes H
Biochemistry; 2004 Jun; 43(25):8152-9. PubMed ID: 15209511
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
12. Tripartite interactions between Wnt signaling, Notch and Myb for stem/progenitor cell functions during intestinal tumorigenesis.
Germann M; Xu H; Malaterre J; Sampurno S; Huyghe M; Cheasley D; Fre S; Ramsay RG
Stem Cell Res; 2014 Nov; 13(3 Pt A):355-66. PubMed ID: 25290188
[TBL] [Abstract][Full Text] [Related]
13. Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation.
Jain P; Surrey LF; Straka J; Luo M; Lin F; Harding B; Resnick AC; Storm PB; Buccoliero AM; Santi M; Li MM; Waanders AJ
Acta Neuropathol; 2018 Jul; 136(1):167-169. PubMed ID: 29767381
[No Abstract] [Full Text] [Related]
14. c-MYB- and PGC1a-dependent metabolic switch induced by MYBBP1A loss in renal cancer.
Felipe-Abrio B; Verdugo-Sivianes EM; Carnero A
Mol Oncol; 2019 Jul; 13(7):1519-1533. PubMed ID: 31066170
[TBL] [Abstract][Full Text] [Related]
15. B-myb proto-oncogene products interact in vivo with each other via the carboxy-terminal conserved region.
Kim T; Jung H; Min S; Kim KT; Ha H
FEBS Lett; 1999 Oct; 460(2):363-8. PubMed ID: 10544265
[TBL] [Abstract][Full Text] [Related]
16. Exploration of binding affinity and selectivity of brucine with G-quadruplex in the c-myb proto-oncogene by electrospray ionization mass spectrometry.
Li H; Hai J; Zhou J; Yuan G
Rapid Commun Mass Spectrom; 2016 Feb; 30(3):407-14. PubMed ID: 26754134
[TBL] [Abstract][Full Text] [Related]
17. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.
Malaterre J; Pereira L; Putoczki T; Millen R; Paquet-Fifield S; Germann M; Liu J; Cheasley D; Sampurno S; Stacker SA; Achen MG; Ward RL; Waring P; Mantamadiotis T; Ernst M; Ramsay RG
Oncogene; 2016 May; 35(19):2475-84. PubMed ID: 26300002
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein L4 positively regulates activity of a c-myb proto-oncogene product.
Egoh A; Nosuke Kanesashi S; Kanei-Ishii C; Nomura T; Ishii S
Genes Cells; 2010 Aug; 15(8):829-41. PubMed ID: 20604807
[TBL] [Abstract][Full Text] [Related]
19. Pim-1 phosphorylates the DNA binding domain of c-Myb.
Winn LM; Lei W; Ness SA
Cell Cycle; 2003; 2(3):258-62. PubMed ID: 12734436
[TBL] [Abstract][Full Text] [Related]
20. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
